$FOLD, Amicus Therapeutics Inc. (FOLD) Trading 10.2%

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz
$FOLD,

Amicus Therapeutics Inc. (FOLD) Trading 10.2% Higher on Insider Buying Activity

Posted by Eileen French on Dec 25th, 2016 // No Comments

Amicus Therapeutics logoAmicus Therapeutics Inc. (NASDAQ:FOLD) shares traded up 10.2% during trading on Friday after an insider bought additional shares in the company. The company traded as high as $5.01 and last traded at $4.99, with a volume of 3,655,041 shares trading hands. The stock had previously closed at $4.53.

Specifically, major shareholder Perceptive Advisors Llc acquired 189,500 shares of the firm’s stock in a transaction on Thursday, December 22nd. The stock was acquired at an average cost of $4.51 per share, for a total transaction of $854,645.00. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, insider Hung Do sold 25,000 shares of Amicus Therapeutics stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $7.00, for a total transaction of $175,000.00. Following the sale, the insider now owns 533,453 shares of the company’s stock, valued at $3,734,171. The disclosure for this sale can be found here. Company insiders own 3.40% of the company’s stock.

FOLD has been the subject of several research reports. Zacks Investment Research cut shares of Amicus Therapeutics from a “hold” rating to a “sell” rating in a research note on Wednesday, November 23rd. Leerink Swann restated a “buy” rating and set a $17.00 price objective on shares of Amicus Therapeutics in a research note on Tuesday, November 8th. Robert W. Baird restated a “hold” rating and set a $7.00 price objective (down from $9.00) on shares of Amicus Therapeutics in a research note on Tuesday, November 29th. Cowen and Company restated an “outperform” rating and set a $12.00 price objective (down from $15.00) on shares of Amicus Therapeutics in a research note on Wednesday, November 30th. Finally, JPMorgan Chase & Co. restated an “overweight” rating and set a $11.00 price objective (down from $12.00) on shares of Amicus Therapeutics in a research note on Wednesday, November 30th. One analyst has rated the stock with a sell rating, two have given a hold rating and six have given a buy rating to the company’s stock. Amicus Therapeutics has an average rating of “Buy” and a consensus price target of $11.08.

The stock’s 50-day moving average is $6.94 and its 200-day moving average is $6.77. The stock’s market capitalization is $710.21 million.

Amicus Therapeutics (NASDAQ:FOLD) last announced its quarterly earnings results on Monday, November 7th. The biopharmaceutical company reported ($0.33) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.34) by $0.01. The company earned $2.10 million during the quarter, compared to analysts’ expectations of $1.71 million. On average, equities analysts anticipate that Amicus Therapeutics Inc. will post ($1.41) earnings per share for the current year.

Institutional investors have recently made changes to their positions in the stock. Pictet Asset Management Ltd. raised its position in shares of Amicus Therapeutics by 674.9% in the second quarter. Pictet Asset Management Ltd. now owns 4,707,381 shares of the biopharmaceutical company’s stock valued at $33,328,000 after buying an additional 4,099,881 shares in the last quarter. Victory Capital Management Inc. bought a new position in shares of Amicus Therapeutics during the third quarter valued at approximately $29,750,000. Jennison Associates LLC raised its position in shares of Amicus Therapeutics by 53.6% in the third quarter. Jennison Associates LLC now owns 7,906,476 shares of the biopharmaceutical company’s stock valued at $58,508,000 after buying an additional 2,759,262 shares in the last quarter. Redmile Group LLC raised its position in shares of Amicus Therapeutics by 14.8% in the third quarter. Redmile Group LLC now owns 12,751,536 shares of the biopharmaceutical company’s stock valued at $94,361,000 after buying an additional 1,645,090 shares in the last quarter. Finally, CQS Cayman LP bought a new position in shares of Amicus Therapeutics during the second quarter valued at approximately $7,589,000.

About Amicus Therapeutics

Amicus Therapeutics, Inc is a biopharmaceutical company. The Company is focused on the discovery and development of therapies to treat a range of rare and orphan diseases. Its lead product candidate, migalastat HCl (Galafold), is an orally administered small molecule pharmacological chaperone for the treatment of Fabry disease, which is a type of lysosomal storage disorder (LSD).

5 Day Chart for NASDAQ:FOLD
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
York Space Systems Faces Class Action Over Misleading IPO

Updated Category News Views 2

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

Continue Reading
China's Manufacturing: Squeeze or Opportunity?

Updated Category News Views 3

Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...

Continue Reading
See's Candies Data Breach Spurs Legal Scrutiny

Updated Category News Views 12

Data Breach Hits See's Candies Hard Amidst Ransomware Attack Alright, folks, here's a not-so-sweet tale to kick off your day — See's Candies has found itself in a bit of a pickle. A ransomware attack, the nasty kind that makes you double-check your locks and your passwords, has reportedly exposed the personal data of its customers and employees. We're talking names,...

Continue Reading
Ice-Rock Avalanches: Future Risks and Urgent Lessons

Updated Category News Views 1

Mounting Threats in Mountain Chains That nightmare on August 26 at Mount Langtang Lirung in Nepal—where an ice-rock avalanche triggered a catastrophic mudslide—brought a harsh reminder that these mountains are cracking wide open. With 31 dead and over 500 souls still unaccounted for, it's a chilling warning about how vulnerable high-altitude regions have become. A...

Continue Reading
Media Forum Spotlights Asia-Pacific Cooperation

Updated Category News Views 3

The Opening Scene: A Gathering with Purpose Well, here we go, diving right into the latest shindig in Shenzhen at the Asia-Pacific Media Forum. Held in China's Guangdong province, they've rounded up over 400 reps from every corner of the globe, all chewing over one key theme: "Building a Path to Shared Prosperity for the Asia-Pacific Community." You could say it's a step...

Continue Reading
ATTACK SHARK Partners with Cloud9 League Team

Updated Category News Views 2

Shaking Hands with Cloud9 ATTACK SHARK is jumping headfirst into the esports game, teaming up with Cloud9's League of Legends team. Now, before you roll your eyes at another corporate matchmaking play, consider the magic at play here. League of Legends isn't just any game; it's a titan in the esports universe, and partnering with Cloud9 offers a serious boost. It's not...

Continue Reading
Summit Tackles BRI Infrastructure's Role in Global SDGs

Updated Category News Views 0

A Bold Gathering with Lofty Goals Ever watch a room of world leaders debate the finer nuances of sustainable infrastructure? That's something Singapore pulled off on September 6, 2026, with the Second Global Business Summit on Belt and Road Infrastructure Investment. These aren't just any ordinary suits sitting around in a conference room. We're talking about a dynamic...

Continue Reading
Zendure, SolarFlow Pro Win Big at IFA 2026 Tech Awards

Updated Category News Views 2

Trophy Time for Zendure in Berlin The Berlin Chronicles of 2026 tell an interesting tale for Zendure—a tale where top honors and glowing recognition highlight its efforts in the sustainable energy arena. At the Global Product Technology Innovation Awards, Zendure's SolarFlow 4000 Mix Pro snagged the Gold for Sustainable Home Energy Storage System. Not only that, but...

Continue Reading
Creality Rolls Out K3, SPARKX i8 at IFA 2026

Updated Category News Views 11

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....

Continue Reading

Top 5 Most Recently Viewed Articles

Green Valley Therapy Launches New Office to Serve More Clients

Updated Category News Views 200

Green Valley Therapy Expands Its Reach with New Location Holistic mental health support is now more accessible with Green Valley Therapy's newly opened office in downtown Frederick. This expansion marks a significant step in the practice's commitment to providing high-quality mental health services to the community. New Office Location and Services The new office is...

Continue Reading
Uniting America Behind Bobsled and Skeleton Teams: A New Initiative

Updated Category News Views 92

Empowering Excellence in Bobsled and Skeleton Sports In a remarkable effort to support American winter sports, USA Bobsled/Skeleton and The Uptown Agency have partnered to create the "50 States Strong" initiative. This nationwide movement is focused on rallying fans and supporters from every corner of the United States, dedicated to advancing the future of bobsledding and...

Continue Reading
MSBAI Pioneers Air Mobility with NASA's Innovative Support

Updated Category News Views 211

MSBAI Chosen for Advanced Air Mobility Contract In an exciting development for the aerospace industry, MSBAI has been awarded a Phase I STTR contract from NASA. This contract focuses on the Model-Based Enterprise (T11.05) topic, aimed at prototyping MBE-GURU and delivering this advanced tool as a managed service through MSBAI's GURU Generation 2 platform. This partnership...

Continue Reading
ArriVent's Firmonertinib Displays Promise for Lung Cancer Treatment

Updated Category News Views 78

Exciting Advances with Firmonertinib for NSCLC Patients ArriVent BioPharma has achieved remarkable progress with its leading treatment, Firmonertinib, aimed at patients with non-small cell lung cancer (NSCLC) who have uncommon EGFR mutations, particularly PACC mutations. Recent interim results from a global Phase 1b study revealed that Firmonertinib has a striking overall...

Continue Reading
Resolute CS Enhances Connectivity Solutions with NEXUS Software

Updated Category News Views 88

Resolute CS Enhances Connectivity Solutions with NEXUS Software Resolute CS, a pioneering connectivity technology firm, has recently acquired NEXUS, an innovative connectivity software platform. This strategic acquisition positions Resolute CS at the forefront of transforming global connectivity procurement, leveraging new technologies to enhance efficiency and customer...

Continue Reading